Jeil Pharma Holdings Inc (KRX:002620)
South Korea
· Delayed Price · Currency is KRW 8,340.00
+140.00 (1.71%)
At close: Dec 5, 2025
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2005 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2005 - 2019 |
| Pharmaceutical | 794.70B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Pharmaceutical Growth | -2.90% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Investment | 14.65B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Investment Growth | 7.04% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Consolidated Adjustment | -29.53B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Consolidated Adjustment Growth | 5.30% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Consolidated Adjustment | -29.53B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Consolidated Adjustment Growth | 5.30% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2005 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2005 - 2019 |
| Consolidated Adjustment | -29.53B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Consolidated Adjustment Growth | 5.30% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| South Korea | 756.49B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| South Korea Growth | -2.66% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Overseas | 52.86B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Overseas Growth | -3.75% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Consolidated Adjustment | -29.53B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Consolidated Adjustment Growth | 5.30% |
Log In |
Log In |
Log In |
Log In | Upgrade
|